ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly total equity ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets (Postgres DB)
Latest, Q2 2026
33,879
Period ended Jun 30, 2026
Change on a year earlier
+84.6%
18,349 in Q2 2025
History
68 quarters
Since Q4 2008
Sources
63
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 33,879 | +84.6% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 31,198 | +96.9% | Form 10-Q (filed 2026-04-30) ↗ |
| Q4 2025 | Dec 31, 2025 | 26,535 | +85.9% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2025 | Sep 30, 2025 | 23,851 | +66.5% | Form 10-Q (filed 2025-10-30) ↗ |
| Q2 2025 | Jun 30, 2025 | 18,349 | +34.6% | Form 10-Q (filed 2025-08-07) ↗ |
| Q1 2025 | Mar 31, 2025 | 15,847 | +22.9% | Form 10-Q (filed 2025-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 14,272 | +31.4% | Form 10-K (filed 2026-02-12) ↗ |
| Q3 2024 | Sep 30, 2024 | 14,321 | +26.6% | Form 10-Q (filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 13,636 | +22.3% | Form 10-Q (filed 2024-08-08) ↗ |
| Q1 2024 | Mar 31, 2024 | 12,897 | +14.2% | Form 10-Q (filed 2024-04-30) ↗ |
| Q4 2023 | Dec 31, 2023 | 10,864 | +0.8% | Form 10-K (filed 2024-02-21) ↗ |
| Q3 2023 | Sep 30, 2023 | 11,307 | +11.2% | Form 10-Q (filed 2023-11-02) ↗ |
| Q2 2023 | Jun 30, 2023 | 11,149 | +28.8% | Form 10-Q (filed 2023-08-08) ↗ |
| Q1 2023 | Mar 31, 2023 | 11,295 | +19.4% | Form 10-Q (filed 2023-04-27) ↗ |
| Q4 2022 | Dec 31, 2022 | 10,775 | +17.7% | Form 10-K (filed 2023-02-22) ↗ |
| Q3 2022 | Sep 30, 2022 | 10,166 | +27.8% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 8,659 | +29.9% | Form 10-Q (filed 2022-08-04) ↗ |
| Q1 2022 | Mar 31, 2022 | 9,462 | +33.3% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Dec 31, 2021 | 9,155 | +57.2% | Form 10-K (filed 2022-02-23) ↗ |
| Q3 2021 | Sep 30, 2021 | 7,954 | +59.2% | Form 10-Q (filed 2021-10-27) ↗ |
| Q2 2021 | Jun 30, 2021 | 6,664 | +56.0% | Form 10-Q (filed 2021-08-03) ↗ |
| Q1 2021 | Mar 31, 2021 | 7,099 | +122.0% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Dec 31, 2020 | 5,825 | +115.8% | Form 10-K (filed 2021-02-17) ↗ |
| Q3 2020 | Sep 30, 2020 | 4,996 | +44.3% | Form 10-Q (filed 2020-10-28) ↗ |
| Q2 2020 | Jun 30, 2020 | 4,272 | +49.5% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 3,197 | +24.6% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,699 | -75.3% | Form 10-K (filed 2020-02-19) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,462 | -75.5% | Form 10-Q (filed 2019-10-25) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,857 | -75.4% | Form 10-Q (filed 2019-08-02) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,565 | -82.4% | Form 10-Q (filed 2019-05-02) ↗ |
| Q4 2018 | Dec 31, 2018 | 10,909 | -6.5% | Form 10-K (filed 2019-02-19) ↗ |
| Q3 2018 | Sep 30, 2018 | 14,151 | -5.4% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 11,621 | -18.0% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | 14,588 | +3.4% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 11,668 | -17.1% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 14,961 | -4.2% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | 14,170 | -3.3% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 14,104 | -6.2% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | 14,081 | -3.4% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2016 | Sep 30, 2016 | 15,616 | +2.5% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 14,656 | -0.3% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | 15,029 | +0.6% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | 14,571 | -5.2% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2015 | Sep 30, 2015 | 15,241 | -13.8% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 14,705 | -18.3% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | 14,947 | -18.5% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 15,373 | -12.8% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2014 | Sep 30, 2014 | 17,683 | – | Form 10-Q (filed 2014-10-29) ↗ |
| Q2 2014 | Jun 30, 2014 | 17,995 | +18.1% | Form 10-Q (filed 2014-07-28) ↗ |
| Q1 2014 | Mar 31, 2014 | 18,349 | +22.7% | Form 10-Q (filed 2014-04-28) ↗ |
| Q4 2013 | Dec 31, 2013 | 17,631 | +19.4% | Form 10-K (filed 2016-02-19) ↗ |
| Q2 2013 | Jun 30, 2013 | 15,236 | +6.5% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | 14,956 | +0.9% | Form 10-Q (filed 2013-04-26) ↗ |
| Q4 2012 | Dec 31, 2012 | 14,765 | +9.0% | Form 10-K (filed 2015-02-19) ↗ |
| Q3 2012 | Sep 30, 2012 | 16,057 | +6.6% | Form 10-Q (filed 2012-10-26) ↗ |
| Q2 2012 | Jun 30, 2012 | 14,308 | – | Form 10-Q (filed 2012-07-27) ↗ |
| Q1 2012 | Mar 31, 2012 | 14,823 | +6.4% | Form 10-Q (filed 2012-04-30) ↗ |
| Q4 2011 | Dec 31, 2011 | 13,542 | +9.0% | Form 10-K (filed 2014-02-19) ↗ |
| Q2 2011 | Sep 30, 2011 | 15,058 | +21.4% | Form 10-Q (filed 2011-10-28) ↗ |
| Q1 2011 | Mar 31, 2011 | 13,934 | +33.2% | Form 10-Q (filed 2011-04-29) ↗ |
| Q4 2010 | Dec 31, 2010 | 12,420 | +30.4% | Form 10-K (filed 2014-02-19) ↗ |
| Q3 2010 | Sep 30, 2010 | 12,406 | +25.2% | Form 10-Q (filed 2010-10-29) ↗ |
| Q2 2010 | Jun 30, 2010 | 10,235 | +19.6% | Form 10-Q/A (filed 2010-08-02) ↗ |
| Q1 2010 | Mar 31, 2010 | 10,462 | – | Form 10-Q (filed 2010-04-30) ↗ |
| Q4 2009 | Dec 31, 2009 | 9,525 | +41.4% | Form 10-K (filed 2010-02-22) ↗ |
| Q3 2009 | Sep 30, 2009 | 9,905 | – | Form 10-Q (filed 2009-10-30) ↗ |
| Q2 2009 | Jun 30, 2009 | 8,560 | – | Form 10-Q (filed 2009-07-31) ↗ |
| Q4 2008 | Dec 31, 2008 | 6,738 | – | Form 10-Q (filed 2009-07-31) ↗ |
Breakdown
What makes up total equity ($m)
- Common stock ($M)588 · Q2 2026
- Additional paid-in capital ($M)7,117 · Q2 2026
- Retained earnings ($M)31,893 · Q2 2026
- Accumulated other comprehensive loss ($M)-2,761 · Q2 2026
- Cost of common stock in treasury ($M) [through Q3 2025]-62.5 · Q3 2025
- Noncontrolling interests ($M) [through Q3 2025]57.5 · Q3 2025
Cite this data
StockData. (2026). Eli Lilly Total equity ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_eq
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.